Cargando…
Reversal of multidrug resistance in leukemia cells using a transferrin-modified nanomicelle encapsulating both doxorubicin and psoralen
To ameliorate multidrug resistance (MDR) observed in leukemia cells, nanomicelles modified by transferrin (Tf-M-DOX/PSO), coencapsulating doxorubicin (DOX) and psoralen (PSO), were designed, synthesized and tested in K562 and doxorubicin-resistant K562 (K562/DOX) cells. In vitro drug release kinetic...
Autores principales: | Wang, He-Wen, Ma, Ke-Ling, Liu, Hua, Zhou, Jia-Yun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7185111/ https://www.ncbi.nlm.nih.gov/pubmed/32259795 http://dx.doi.org/10.18632/aging.102992 |
Ejemplares similares
-
Nanomicelles loaded with doxorubicin and curcumin for alleviating multidrug resistance in lung cancer
por: Gu, Yue, et al.
Publicado: (2016) -
Exosomes play an important role in the process of psoralen reverse multidrug resistance of breast cancer
por: Wang, Xiaohong, et al.
Publicado: (2016) -
Doxorubicin-transferrin conjugate selectively overcomes multidrug resistance in leukaemia cells
por: Łubgan, Dorota, et al.
Publicado: (2008) -
Psoralen-loaded lipid-polymer hybrid nanoparticles enhance doxorubicin efficacy in multidrug-resistant HepG2 cells
por: Yuan, Yueling, et al.
Publicado: (2019) -
Preparation of psoralen polymer–lipid hybrid nanoparticles and their reversal of multidrug resistance in MCF-7/ADR cells
por: Huang, Qingqing, et al.
Publicado: (2018)